Skip to main content
. Author manuscript; available in PMC: 2015 Oct 1.
Published in final edited form as: Endocr Relat Cancer. 2015 Jun;22(3):277–287. doi: 10.1530/ERC-14-0586

Figure 6. INPP4B loss decreases time to biochemical recurrence in prostate cancers expressing the TMPRSS2/ERG fusion gene.

Figure 6

Kaplan Meier analysis of time to biochemical recurrence following radical prostatectomy of ERG positive cancers with low (“0-5”, n=65) or high (“6-9”, n=103) INPP4B Index. The Log-rank Test p-value is 0.023.